体外试验已表明,从人类肿瘤组织内分离出来的淋巴细胞对自身的肿瘤具有更强的特异性免疫反应。但由于其分离和大量淋巴细胞的产生有困难,故一直未能用于临床治疗。本文作者用IL—2来培养这些细胞,并把这种淋巴细胞试用于临床治疗。 作者挑选了7名活检已证实是肺部转移性腺癌并已不能进行手术治疗的晚期病人。6名通过活检的方 In vitro experiments have shown that lymphocytes isolated from human tumor tissue have a stronger specific immune response to their own tumors. However, it has not been used for clinical treatment due to difficulties in its isolation and the production of large numbers of lymphocytes. The authors used IL-2 to culture these cells and tried the lymphocytes for clinical treatment. The authors selected seven patients with advanced metastases that had been confirmed to be metastatic adenocarcinoma of the lung and could not be treated surgically. 6 parties passed biopsy